Durso-Bumpus Debra — SEC Form 4 filings
SEC reporting owner CIK 1802970. 8 Form 4 filings on record with FilingPulse; latest filed 2025-07-21.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-06 to 2025-07-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 5 filings — 97,284 shares, $10,079,740 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 29.
- Largest priced transaction: sale of 40,353 shares @ $104.14 ($4,202,361) in Blueprint Medicines Corp, filed 2024-06-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Blueprint Medicines Corp (BPMC) | Chief People Officer | 8 | — | 10 legs · 97,284 sh · $10,079,740 | 29 |
Form 4 filings — Durso-Bumpus Debra
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-07-21 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 21,353 · Disposition to issuer (D): 51,103 · Code (U): 19,856 · Disposition to issuer (D): 15,367 (derivative) · Disposition to issuer (D): 30,500 (derivative) · Disposition to issuer (D): 21,125 (derivative) · +5 more | EDGAR |
| 2025-03-07 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 5,157 @ $88.80 | EDGAR |
| 2025-03-04 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 11,000 @ $0 · Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2024-07-08 | 4 | Blueprint Medicines Corp (BPMC) | Option exercise (M): 8,817 @ $54.13 · Sale (S): 8,817 @ $111.29 · Option exercise (M): 3,850 @ $54.13 · Sale (S): 3,850 @ $111.20 · Option exercise (M): 8,817 (derivative) @ $0 · Option exercise (M): 3,850 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Blueprint Medicines Corp (BPMC) | Option exercise (M): 333 @ $54.13 · Sale (S): 333 @ $111.15 · Option exercise (M): 333 (derivative) @ $0 | EDGAR |
| 2024-06-25 | 4 | Blueprint Medicines Corp (BPMC) | Option exercise (M): 13,741 @ $18 · Option exercise (M): 7,041 @ $18 · Option exercise (M): 24,200 @ $36.05 · Option exercise (M): 15,500 @ $54.13 · Sale (S): 1,567 @ $105.82 · Sale (S): 18,752 @ $104.98 · +7 more | EDGAR |
| 2024-03-11 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 5,093 @ $90.69 | EDGAR |
| 2024-03-06 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 12,500 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1802970 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →